Dec 12 (Reuters) - The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's ...
The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...
Dec 12 (Reuters) - The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's ...
In the digital era, being exposed to medical misinformation online is an everyday fact of life. Early research examining how social media, in particular, spreads misinformation about established ...
Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. Now this rapidly growing patient population is a step closer to gaining access to Eli ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It may be time to add Covid-19 infection to the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Youths receiving tirzepatide had a 2.28 percentage point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback